Accessibility settings

This paper is in the following e-collection/theme issue:

Pilot studies (ehealth) (354) Text-messaging (SMS, WeChat etc)-Based Interventions (783) Web-based and Mobile Health Interventions (4229) Formative Studies and eHealth/mHealth Development (597) Health Coaching for Diabetes Patients (183) Diabetes Prevention (130) Diabetes Technology Around the World (34)

Published on in Vol 10 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/76993, first published .
A Text Messaging–Based Program to Transition From Basal Insulin to Glucagon-Like Peptide-1 Receptor Agonists in Safety-Net Diabetes Care: Pilot Quality Improvement Intervention Study

A Text Messaging–Based Program to Transition From Basal Insulin to Glucagon-Like Peptide-1 Receptor Agonists in Safety-Net Diabetes Care: Pilot Quality Improvement Intervention Study

A Text Messaging–Based Program to Transition From Basal Insulin to Glucagon-Like Peptide-1 Receptor Agonists in Safety-Net Diabetes Care: Pilot Quality Improvement Intervention Study

Authors of this article:

Natalie Levy1, 2 Author Orcid Image ;   Katie Nerlino1, 2 Author Orcid Image ;   Sherlane Bongalos3 Author Orcid Image ;   Alex Dasilva3 Author Orcid Image ;   Chinye Uzor3 Author Orcid Image ;   Ying Jie Liang3 Author Orcid Image ;   Olubunmi Sonubi3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Natalie Levy   1, 2 , MD ;   Katie Nerlino   1, 2 , BA ;   Sherlane Bongalos   3 , BSN, RN ;   Alex Dasilva   3 , BSN, RN ;   Chinye Uzor   3 , BSN, RN ;   Ying Jie Liang   3 , BSN, RN ;   Olubunmi Sonubi   3 , MSN, RN, CDCES

1 Division of General Internal Medicine and Clinical Innovation, NYU Grossman School of Medicine, New York, NY, United States

2 Department of Medicine, NYC Health + Hospital/Bellevue, New York, NY, United States

3 Department of Nursing, NYC Health + Hospitals/Bellevue, New York, NY, United States

Corresponding Author:

  • Natalie Levy, MD
  • Division of General Internal Medicine and Clinical Innovation
  • NYU Grossman School of Medicine
  • OBV - A620, 462 First Avenue
  • New York, NY 10016
  • United States
  • Email: natalie.levy@nyulangone.org